Concepedia

Matthew D. Weitzman

MD

7

Publications

304

Citations

7

H-Index

2003

Active since

Affiliations

Yale University(Current)

Kyushu University

Institute of Molecular Medicine

University of California San Diego

University of Delaware

Matthew D. Weitzman is an author at Yale University specializing in medicine, molecular biology, and biophysics.

ORCID

Top concepts

Publications per year

2003–2019

7

Publications

7

The suppressor of cytokine signaling–1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury

Hideo Yasukawa, Toshitaka Yajima, Hervé Duplain et al. · Journal of Clinical Investigation · 2003 · 117 citations · Full text

Analysis of the RPE transcriptome reveals dynamic changes during the development of the outer blood-retinal barrier.

Lawrence J. Rizzolo, Xiang Chen, Matthew D. Weitzman et al. · PubMed · 2007 · 40 citations

Expression of JAM-A, AF-6, PAR-3 and PAR-6 during the assembly and remodeling of RPE tight junctions

Yan Luo, Masayuki Fukuhara, Matthew D. Weitzman et al. · Brain Research · 2006 · 36 citations

, , +2

Membrane-Permeant, Environment-Sensitive Dyes Generate Biosensors within Living Cells

Christopher J. MacNevin, Takashi Watanabe, Matthew D. Weitzman et al. · Journal of the American Chemical Society · 2019 · 36 citations · Full text

Caveolin‐1 Mediates Inflammatory Breast Cancer Cell Invasion via the Akt1 Pathway and RhoC GTPase

Madhura Joglekar, Weam O. Elbazanti, Matthew D. Weitzman et al. · Journal of Cellular Biochemistry · 2015 · 36 citations

, , +15

Rows per page

1–5 of 7